Stephen R. Murray
Plus aucun poste en cours
Profil
Stephen R.
Murray worked as a Medical Director and Senior Medical Director at Pfizer Inc. and Pfizer Global Pharmaceuticals, respectively, from 2001 to 2006.
He then served as the Chief Medical Officer at Memory Pharmaceuticals Corp.
from 2006 to 2009.
After that, he worked as the Vice President of Pharmaceutical Operations at Omeros Corp.
in 2009.
He also held the position of Assistant Medical Director at Janssen Pharmaceutica NV and Chief Medical Officer at Affectis Pharmaceuticals AG and Clinilabs, Inc. Dr. Murray earned a doctorate degree from the Medical University of South Carolina and an undergraduate degree from the University of South Carolina.
Anciens postes connus de Stephen R. Murray
| Sociétés | Poste | Fin |
|---|---|---|
Memory Pharmaceuticals Corp.
 Memory Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Memory Pharmaceuticals Corp. develops pharmaceutical products for the treatment of debilitating central nervous system (CNS) disorders such as Alzheimer's disease and schizophrenia. The company was founded by Axel Unterbeck in 1998 and is headquartered in Montvale, NJ. | Directeur Technique/Scientifique/R&D | 01/01/2009 |
Pfizer Global Pharmaceuticals, Inc.
 Pfizer Global Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pfizer Global Pharmaceuticals, Inc. manufactures, and markets prescription medicines. It markets medicines for diseases which include infections, arthritis, depression, hypertension and other heart disorders, as well as certain types of cancer. Pfizer Global Pharmaceuticals is located in New York, NY. | Directeur Technique/Scientifique/R&D | 01/01/2006 |
| PFIZER, INC. | Directeur Technique/Scientifique/R&D | 01/01/2004 |
Clinilabs, Inc.
 Clinilabs, Inc. Miscellaneous Commercial ServicesCommercial Services Clinilabs, Inc. provides contract research services to the pharmaceutical and biotechnology companies. It offers data services such as data management, programming, biostatistics, and technology solutions. The company was founded by Gary K. Zammit in 2001 and is headquartered in New York, NY. | Directeur Technique/Scientifique/R&D | - |
Affectis Pharmaceuticals AG
 Affectis Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Affectis Pharmaceuticals AG discovers and develops drugs for the treatment of neurodegenerative and neuroinflammatory diseases. Its products in pipeline include AFC-5128, P2X7 Compounds, AFC-5278 and AFC-08. The company was founded in January 2004 by Florian Holsboer, Wolfgang Wurst and Herbert Stadler and is headquartered in Dortmund, Germany. | Directeur Technique/Scientifique/R&D | - |
Formation de Stephen R. Murray
| University of South Carolina | Undergraduate Degree |
| Medical University of South Carolina | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| OMEROS CORPORATION | Health Technology |
| Entreprise privées | 5 |
|---|---|
Memory Pharmaceuticals Corp.
Memory Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Memory Pharmaceuticals Corp. develops pharmaceutical products for the treatment of debilitating central nervous system (CNS) disorders such as Alzheimer's disease and schizophrenia. The company was founded by Axel Unterbeck in 1998 and is headquartered in Montvale, NJ. | Health Technology |
Pfizer Global Pharmaceuticals, Inc.
Pfizer Global Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pfizer Global Pharmaceuticals, Inc. manufactures, and markets prescription medicines. It markets medicines for diseases which include infections, arthritis, depression, hypertension and other heart disorders, as well as certain types of cancer. Pfizer Global Pharmaceuticals is located in New York, NY. | Health Technology |
Janssen Pharmaceutica NV
 Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium. | Health Technology |
Affectis Pharmaceuticals AG
Affectis Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Affectis Pharmaceuticals AG discovers and develops drugs for the treatment of neurodegenerative and neuroinflammatory diseases. Its products in pipeline include AFC-5128, P2X7 Compounds, AFC-5278 and AFC-08. The company was founded in January 2004 by Florian Holsboer, Wolfgang Wurst and Herbert Stadler and is headquartered in Dortmund, Germany. | Health Technology |
Clinilabs, Inc.
Clinilabs, Inc. Miscellaneous Commercial ServicesCommercial Services Clinilabs, Inc. provides contract research services to the pharmaceutical and biotechnology companies. It offers data services such as data management, programming, biostatistics, and technology solutions. The company was founded by Gary K. Zammit in 2001 and is headquartered in New York, NY. | Commercial Services |